Missouri lawmakers seek to gag pharmacists on ivermectin, hydroxychloroquine sulfate

Missouri lawmakers recently passed a bill to restrict pharmacists from telling patients about risks around ivermectin and hydroxychloroquine sulfate — both sometimes used to treat COVID-19 despite having no FDA clearance for that use. St. Louis University sociologist Liz Chiarello explains how the bill fits into recent political battles affecting pharmacists.